CEL — Celadon Pharmaceuticals Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- £9.23m
- £14.01m
- £0.08m
REG - Celadon Pharma. PLC - Supply of Products to New US Customer
AnnouncementREG - AIM - AIM Notice - 21/05/2024
AnnouncementREG - Celadon Pharma. PLC - Exercise of Share Options and Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 15/05/2024
AnnouncementREG - Celadon Pharma. PLC - Final Results
AnnouncementREG - Celadon Pharma. PLC - Fundraise, RCF Extension, Termination of CLN & TVR
AnnouncementRCS - Celadon Pharma. PLC - Early Economic Analysis of Feasibility Study Data
AnnouncementREG - AIM - AIM Notice - 18/12/2023
AnnouncementREG - Celadon Pharma. PLC - Product Supplied to First Two Sales Contracts
AnnouncementREG - Celadon Pharma. PLC - Fundraise, Update on Future CLN Financing & TVR
AnnouncementREG - Celadon Pharma. PLC - New European Sales Contract
AnnouncementREG - Celadon Pharma. PLC - Fundraise, CLN Issue, Joint Broker Appointed & TVR
AnnouncementREG - Celadon Pharma. PLC - Interim Results
AnnouncementREG - Celadon Pharma. PLC - Notice of Results and Investor Presentation
AnnouncementREG - Celadon Pharma. PLC - New Sales Contract with UK Pharmaceutical Company
AnnouncementREG - Celadon Pharma. PLC - Approval to roll-out chronic pain clinical trial
AnnouncementREG - Celadon Pharma. PLC - Result of AGM
AnnouncementREG - Celadon Pharma. PLC - Publication of Annual Report and Notice of AGM
AnnouncementREG - Celadon Pharma. PLC - Final Results for the year ended 31 December 2022
Announcement